Larvol Delta - Machine-Learning-Model-Predicts-Clinical-Adverse-Events-of-Small-Molecule-Kinase-Inhibitors-in-Cancer-Patients-Using-OnOffTarget-Engagement-and-Tissue-Selectivity

Nerlynx (neratinib) - Puma

http://www.ncbi.nlm.nih.gov/pubmed/42191644

Albert Cao; Duxin Sun; Natalie M Jusko

May 27, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next